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In rats, vasopressin- and oxytocin-encoding mRNAs are present in the posterior but absent in the anterior lobe of the pituitary gland. RNase 
protection experiments indicate that in the posterior pituitary and hypothalamus identical transcriptional start points are used. Furthermore, the 
two transcripts from posterior pituitary and hypothalamus show identical nucleotide sequences. Animals operated by paired electrical lesions in 
such a way that connections between the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus and the posterior 
pituitary lobe are destroyed continue to express the vasopressin a d oxytocin gene in the hypothalamus but not in the posterior pituitary. Operated 
animals ubjected to chronic intermittent salt loading for 6 days similarly contain vasopressin and oxytocin encoding transcripts in the hypothala- 
mus but not in the posterior pituitary. 
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1. INTRODUCTION 
Expression of the oxytocin-vasopressin gene family 
has been observed in many extrahypothalamic tissues 
such as cerebellum, adrenal gland and reproductive 
organs [1], a list that recently has been extended by the 
unexpected addition of the rat pituitary [2]. Poly(A) + 
RNA extracted from the posterior but not from the 
anterior pituitary contains vasopressin-encoding 
transcripts [2]. These data have been confirmed and ex- 
tended not only for vasopressin- but also for oxytocin- 
encoding mRNA from rat posterior pituitary using 
Northern blot and in situ hybridization techniques 
[3,4]. 
It is presently not known whether the oxytocin and 
vasopressin genes are expressed in pituicytes, a 
modified subtype of astrocytes of the posterior 
pituitary or whether the observed transcripts are pre- 
sent in the nerve-endings of the hypothalamic 
magnocellular neurons. I  the latter case the respective 
mRNAs would have to travel axonally from the cell 
body, localized in the hypothalamus to the nerve en- 
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dings in the posterior pituitary. Unfortunately, because 
of the special morphology of the posterior pituitary in 
situ hybridization at the light microscopy level does not 
allow one to distinguish between the two cell types. 
In this report we show that rat posterior pituitary 
derived vasopressin- and oxytocin-encoding mRNAs 
are identical in sequence to their hypothalamic counter- 
parts and that after physical disconnection of the 
hypothalamo-pituitary t acts by paired electrical e- 
sions, vasopressin and oxytocin encoding mRNAs can 
no longer be detected in the posterior pituitary. 
2. MATERIALS AND METHODS 
2.1. Specific DNA fragments used 
A 199 bp Pstl/Kpnl DNA fragment, corresponding to ucleotide 
residues -36 to + 163 (+ 1 = transcriptional start point) from the rat 
vasopressin gene [5] was cloned into the SmaI/Pstl sites of pSP 65 
after converting the 3' cohesive nds generated by digestion with 
KpnI into blunt ends with T4 DNA polymerase according to standard 
procedures [6]. This clone was designated pSP AVP 5'. Similarly, a 
204 bp ApaI/Mstl DNA fragment, corresponding to nucleotide 
residues -47 to + 157 of the rat oxytocin gene [7] was cloned into the 
Sinai site of pSP 65, after converting the 3' cohesive nds generated 
by digestion with Apa! to blunt ends (clone pSP OT5'). The genomic 
fragments are oriented in the vector in a 3' to 5' direction relative 
to the position of the SP6 promoter. In vitro transcription yielded 
cRNAs representing the anti sense strand of the respective mRNAs. 
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Clones representing the nonhomologous 3' ends of the rat 
vasopressin a d oxytocin genes were constructed by excising a 638 bp 
PstI/HindIII fragment from the vasopressin gene [51 or a 700 bp 
AvaI/EcoRI fragment from the oxytocin gene[7], these being subse- 
quently inserted into the appropriate sites of the vector pUC 8.
Chicken/5' actin cDNA was a kind gift of H.H. Arnold (Hamburg). 
2.2. Electrical lesion experiments 
Male Wistar rats (-200 g) were used in all experiments. Where in- 
dicated, chronic intermittent salt loading with 2°70NaCI in the drink- 
ing water was performed for 6 days as recently described [8]. 
Production of diabetes insipidus in rats was carried out as describ- 
ed in Thorn et al. [9]. In the experimental group (5 rats each), in 
dormicum-hypnorm or brietal anaesthesia, a unipolar electrode was 
introduced through 2 holes made in the skull, at the bregma and as 
close to the midline as possible. The tip was sited midway between the 
optic chiasma and the ventromedial nuclei, and paired lesions were 
produced by 3-4 mA/20 s. The procedure was repeated after 7-10 
days. A stable polyuria occurred approximately 7 days after the se- 
cond operation. Daily water consumption was monitored and 
diuresis and urine osmolality were measured. 
2.3. RNA isolation and Northern blot analysis 
Total RNA from hypothalamus, pituitary gland, anterior d 
posterior pituitary was prepared as published [10]. RNA was 
denatured with glyoxal [6], electrophoresed in 1.45070 agarose gels 
and transferred to Zeta Probe membranes (Bio Rad, Munich, FRG). 
Hybridization was carried out with labelled [11] DNA probes (3-5 x 
10 6 cpm/ml) specific for the vasopressin (638 bp PstI/HindllI in 
pUC 8; [5]) or oxytocin (700 bp AvaI/EcoRl in pUC 8; [7]) genes. 
2.4. PCR amplification of vasopressin a d oxytocin mRNA 
Poly(A) + RNA from rat hypothalami and pituitary glands was 
converted into single stranded cDNAs [12]. 100 ng (hypothalamus) or 
200 ng (pituitary gland) ss cDNA was amplified by the polymerase 
chain reaction i  100/zl of 10 mM Tris-HC1, pH 8.3, 50 mM KC1, 
0.01% gelatine, 0.05°70 Nonidet P40, 0.05070 Tween 20, 1 mM MgCI2, 
200/~M each of dATP, dTTP, dGTP and dCTP, 1 uM of each 
primer (see l gend of Fig. 1) and 2.5 units Taq polymerase (Cetus 
Norwalk, USA). First cycle (1 loop): 5 min, 96°C, 4.5 min, 50°C, 
3 min, 72°C; second cycle (29 loops): 1.5 rnin, 96°C, 1.5 min, 50°C, 
3 rain, 72°C; third cycle (I loop): 1.5 min, 96°C, 1.5 min, 50°C, 
5 rain, 72°C. For reamplification, a 10/A aliquot of the first reaction 
was used under identical conditions. 
Amplified products were resolved on preparative agarose gels, el c- 
trophoretically eluted an cloned into the Sinai site of the vector M 13
mp 18. Sequence determination of template DNAs was performed ac- 
cording to [13]. 
2.5. Southern blot analys& 
PCR products were run on 1.0% agarose gels and transferred to 
nylon membranes (Bio Rad, Munich, FRG) in 0.4 M NaOH [14]. 
Hybridization was carried out with labelled [11] DNA probes (5 x 
105 cpm/ml) specific for the vasopressin or oxytocin gene (638 bp 
PstI/HindIII in pUC 8, 700 bp Aval/EcoRI in pUC 8). 
2.6. RNase protection assays 
RNase protection experiments wereperformed essentially s 
described [15]. Briefly, 5 ug of hypothalamic and 30,ug pituitary 
RNA were dissolved in 30/zl 80% formamide, 40 mM Pipes, pH 6.4, 
400 mM NaC1, 1 mM EDTA and hybridized overnight (>8 h) at 
45°C to a 32p labelled in vitro synthesized vasopressin (pSP AVP 5 ') 
or oxytocin (pSP OT 5') specific anti sense RNA (7 × 105 cpm/reac- 
tion) corresponding to the 5' ends of the respective mRNAs. After 
digestion with RNase A and RNase T1, proteinase K treatment, 
phenol extraction a d alcohol precipitation, protected bands were 
electrophoretically separated in 6% sequencing gels [16]and exposed 
to X-ray films (Fuji RX). 
3. RESULTS 
3.1. Sequence analysis and mapping of  transcriptional 
start points o f  neural lobe vasopressin and 
oxytocin mRNAs  from rat posterior pituitary 
Poly(A) + RNA from rat hypothalamus and the entire 
pituitary gland were converted into single stranded 
cDNA and amplif ied by the polymerase chain reaction 
(PCR) using primers (20-mers) corresponding to the ex- 
treme 5' and 3' ends of either rat hypothalamic 
vasopressin or oxytocin mRNAs [5,7]. Amplif ied pro- 
ducts of the pituitary cDNAs were identical in size to 
those of the hypothalamus and hybridized strongly to 
3Zp labelled probes specific for either vasopressin- or 
oxytocin-encoding transcripts (Fig. 1). The bands cor- 
responding to the largest of the hybridizing fragments 
were subcloned and sequenced. This revealed that 
vasopressin- and oxytocin-encoding mRNAs from 
posterior pituitary and hypothalamus show identical 
nucleotide sequences (Fig. 1). In the hypothalamus, 
several nearby transcriptional start points were shown 
to exist in the vasopressin and oxytocin genes [5,7]. 
RNase protection experiments demonstrate that in 
posterior pituitary and hypothalamus RNAs identical 
patterns of protected bands are observed, occurring in 
the same relative abundance.  Moreover, anterior lobe 
RNA is devoid of both transcripts as indicated by the 
complete absence of protected fragments (Fig. 2). 
3.2. Northern blot analysis after disconnection of  the 
hypothalamo-pituitary t acts 
In a series of experiments he connection between the 
supraoptic nucleus (SON) and paraventricular nucleus 
(PVN) of the hypothalamus and the posterior pituitary 
lobe was destroyed by paired electrical lesions. Whereas 
the urine osmolality of the sham operated group was 
1984 _+ 102 mOsm, the operated animals exhibited a 
severe (urine osmolality 319.8 _+ 46.0 mOsm) or a mild 
(urine osmolality 854.0 _+ 18.2 mOsm) form of diabetes 
insipidus. Sham operated, mildly or severely diabetic 
animals were subjected to chronic intermittent salt 
loading for 6 days. This has previously been shown to 
result in an increase in vasopressin and oxytocin mRNA 
content in the hypothalamus [8]. Each group was 
paralleled by a control group which received tap water 
ad lib. 
Posterior pituitary and hypothalamus RNAs were 
subsequently analyzed by Northern blot hybridization 
to radiolabelled vasopressin- and oxytocin-specific pro- 
bes. The data shown in Fig. 3 reveal several interesting 
features: 
(i) In the posterior pituitary vasopressin- and 
oxytocin-encoding transcripts are virtually absent in all 
groups of lesioned animals (Fig. 3, lanes 5-8).  In sham 
operated animals both mRNA species are easily 
detected and accumulate after salt loading (lanes 3, 4), 
a result that is in agreement with recent reports [3,4]. 
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Fig. 1. Agarose gel electrophoresis and Southern blot analysis of products generated by PCR amplification of single stranded cDNAs derived 
from rat hypothalamus (H) or total pituitary gland mRNA (P). Primers used for amplification of single stranded vasopressin-encoding cDNAs: 
5' AGCAGAGCAGAGCTGCACGC 3' (forward primer) and 5' TTGCATTTTTTAAAAGTTTA 3' (reverse primer), primers used for 
amplification of single stranded oxytocin-encoding cDNAs: 5' ACCATCACCGACGGT GGATC 3' (forward primer) and 5' TTGAAGAGG 
AAATCTGCTTT 3' (reverse primer). (A) Agarose gel electrophoresis of amplified products. (B) Southern blot analysis of PCR amplified 
products using a 32p-labelled vasopressin- or oxytocin-specific probe. (C) Schematic representation of the identity of hypothalamic and pituitary 
mRNAs encoding the vasopressin and oxytocin precursor, espectively. AVP, vasopressin, GP, glycopeptide; H, hypothalamus; M, DNA size 
markers (HaelI1 cut PhiX174 DNA); NP, neurophysin; OT, oxytocin. The hatched boxes indicate the primer sequences. The bars shown on the 
left and right side indicate th  positions of the four largest DNA fragments of HaellI cut PhlXl74 DNA. The dotted lines indicate hat pituitary 
vasopressin and oxytocin mRNA are identical in nucleotide sequence to th ir hypothalamic counterparts [5,7]. 
(ii) Compared  to their hypothalamic ounterparts,  
poster ior  pituitary RNAs are shorter due to a different 
degree of  polyadenylat ion.  
(iii) In the hypothalamus of  sham-operated animals, 
a strong hybr idizat ion signal is observed for both 
vasopressin- and oxytocin-encoding mRNA (lanes 9, 
10). In contrast,  hypothalamic vasopressin encoding 
transcripts are drastical ly reduced in lesioned animals 
showing a severe diabetes insipidus (lanes 11, 12) and 
are moderate ly  reduced in those showing a mild 
diabetes insipidus (lanes 13, 14). This reduction is less 
signif icant for the oxytocin-encoding mRNA (lanes 
11-14). 
(iv) Chronic intermittent salt loading of  lesioned and 
sham-operated animals leads to an increase in the 
length of  the hypothalamus-der ived vasopressin- and 
oxytocin-encoding mRNAs,  most likely due to increas- 
ed polyadenylat ion;  but little if any increase has been 
observed in the level of  the respective hypothalamic 
transcripts (lanes 9-14) .  This is quite in contrast to 
osmotical ly  stressed but not operated animals which ac- 
cumulate hypothalamic  vasopressin- and oxytocin- 
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Fig. 2. RNase protection experiment. Total cellular RNAs from rat hypothalamus (lanes 1, 2, 6, 7), total pituitary gland (lanes 3, 8) and anterior 
lobe of the pituitary gland (lanes 4, 5, 9, 10) were hybridized to 32p labelled anti sense RNAs corresponding to a portion of the 5' untranscribed 
region, the 5' transcribed region as well as exon A of the rat vasopressin (AVP) or oxytocin (OT) gene. The open arrowheads point to the position 
of the major protected bands. DNA size markers (in bases) are shown on the right. H, hypothalamus; AP, anterior pituitary; TP, total pituitary 
gland; SL, salt loading for 7 days. 
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Fig. 3. Northern blot analysis of RNAs extracted from rat hypothalamus (lanes 1, 2, 9-14) and posterior pituitary (lanes 3-8). The filter was 
first hybridized to a aZp labelled vasopressin (AVP)-specific probe and after emoval of hybridized DNA to a labelled oxytocin (OT)-specific 
probe, and finally to a labelled chicken ~ actin cDNA. DNA size markers in bases are indicated on the right. Lanes 1 and 2: Hypothalamic RNA 
from control animals and rats treated with 2070 saline for 7 days, respectively. Five rats each were sham operated (lanes 3, 4, 9, 10) or electrically 
lesioned which produced a severe (lanes 5, 6, 1 1, 12) or mild (lanes 7, 8, 13, 14) artificial diabetes insipidus. In addition, animals were subjected 
to intermittent salt loading for 6 days (lanes 4, 6, 8, 10, 12, 14). Hypothalamic RNA: 3/zg/lane (lanes 1, 2, 1 1-14), about 2/~g/lane (lanes 9, 
10); in these animals RNAs were extracted from individually punched SONs and PVNs, explaining the slightly reduced signal observed for the 
actin mRNA. Posterior pituitary RNA: total RNA extracted from 5 lobes/lane. RNAs shown in lanes 3 and 9, 4 and 10, 5 and 1 1, 6 and 12, 
7 and 13, 8 and 14, respectively, were extracted from hypothalami and posterior pituitary lobes of the same animals. H, hypothalamus; P,
posterior pituitary; SL, salt loading. 335 
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encoding mRNAs that contain signif icantly longer po- 
ly(A) tails (Fig. 3, lanes 1, 2). 
to the high activity of  the pituicytes in phagocytosing 
cell debris resulting f rom the electrical lesion. 
4. D ISCUSSION 
The results presented here show that vasopressin- 
and oxytocin-encoding mRNAs from rat hypothalamus 
and poster ior  pituitary are identical in their nucleotide 
sequence, this agreeing with the idea that vasopressin 
and oxytocin precursors are encoded by single copy 
genes [1]. The only difference observed is that poster ior 
p i tu i tary derived transcripts contain shorter poly(A) 
tails than those found in the hypothalamus.  After  
destruct ion of  the hypotha lamo-p i tu i tary  axis, 
vasopressin- and oxytocin-encoding transcripts are no 
longer detectable in the poster ior pituitary,  even when 
the animals are subjected to chronic intermittent salt 
loading, which in the sham operated control  group 
leads to an accumulat ion of  both mRNA species. These 
f indings might be interpreted to suggest that 
vasopressin- and oxytocin-encoding mRNAs are ax- 
onal ly  t ransported from the hypotha lamus to the 
poster ior  pituitary. However,  this appears rather 
unl ikely, since in order to obtain the shorter poster ior  
p i tu i tary mRNAs  a precise tr imming at the poly(A) tail 
o f  the hypothalamic transcripts would have to occur 
during axonal transport .  
Alternat ively the pituicytes of  the poster ior  pituitary,  
a heterogenous group of  cells [17], could be the site of  
vasopressin and oxytocin gene expression. This being 
the case, our data suggest hat the pituicytes depend on 
contacts with axons of  magnocel lu lar  neurons and/or  
on neural  inputs deriving from other parts of  the brain 
for their abil ity to express the vasopressin and oxytocin 
genes. It may also be that vasopressin and oxytocin 
gene expression is sharply down-regulated in response 
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